Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections

Epidemiology and Infection
N KomadinaJ McVernon

Abstract

The epidemiology of H5N1 and H7N9 avian viruses of humans infected in China differs despite both viruses being avian reassortants that have inherited six internal genes from a common ancestor, H9N2. The median age of infected populations is substantially younger for H5N1 virus (26 years) compared with H7N9 virus (63 years). Population susceptibility to infection with seasonal influenza is understood to be influenced by cross-reactive CD8+ T cells directed towards immunogenic peptides derived from internal viral proteins which may provide some level of protection against further influenza infection. Prior exposure to seasonal influenza peptides may influence the age-related infection patterns observed for H5N1 and H7N9 viruses. A comparison of relatedness of immunogenic peptides between historical human strains and the two avian emerged viruses was undertaken for a possible explanation in the differences in age incidence observed. There appeared to be some relationship between past exposure to related peptides and the lower number of H5N1 virus cases in older populations, however the relationship between prior exposure and older populations among H7N9 virus patients was less clear.

References

May 1, 1980·European Journal of Immunology·R G Webster, B A Askonas
Jan 18, 2008·The New England Journal of Medicine·UNKNOWN Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian InfTimothy M Uyeki
Jul 1, 2010·Emerging Infectious Diseases·Amr KandeelNasr El-Sayed
May 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Chao WuWeisan Chen
Jul 14, 2011·PLoS Medicine·Maria D Van KerkhoveUNKNOWN WHO Working Group for Risk Factors for Severe H1N1pdm Infection
Feb 13, 2013·Immunology and Cell Biology·Emma GrantWeisan Chen
Apr 13, 2013·The New England Journal of Medicine·Rongbao GaoYuelong Shu
Apr 26, 2013·The New England Journal of Medicine·Qun LiZijian Feng
Aug 24, 2013·The Lancet Infectious Diseases·Kelvin K W ToKwok-Yung Yuen
Sep 24, 2013·Nature Medicine·Saranya SridharAjit Lalvani
Jan 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Sergio Quiñones-ParraKatherine Kedzierska
Feb 4, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chen WangLanjuan Li
Apr 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Michael WorobeyAndrew Rambaut
Sep 13, 2014·Future Virology·Mathilde RichardSander Herfst
Apr 7, 2015·American Journal of Respiratory and Critical Care Medicine·Andrew C HaywardAndrew J McMichael
May 6, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ying QinHongjie Yu
Sep 8, 2015·Vaccines·Claudia TrombettaEmanuele Montomoli
Dec 15, 2015·The Lancet Infectious Diseases·J S Malik PeirisGabriel M Leung
May 27, 2016·Journal of Virology·Sergio M Quiñones-ParraKatherine Kedzierska
Apr 7, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Yuelong Shu, John McCauley
Dec 19, 2017·Lancet·A Danielle IulianoUNKNOWN Global Seasonal Influenza-associated Mortality Collaborator Network
Jan 27, 2018·Virology Journal·Giuseppe A SauttoTed M Ross

❮ Previous
Next ❯

Citations

Jan 28, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alain GagnonMatthew S Miller

❮ Previous
Next ❯

Methods Mentioned

BETA
GISAID

Software Mentioned

GISAID
R
Stata
fasta
Geneious

Related Concepts